Bristol Myers Squibb is extending a research collaboration with the artificial intelligence company Insitro to design new medicines against a novel target in amyotrophic lateral sclerosis (ALS). The target was identified […] The post Insitro, Bristol Myers extend research into new drug for ALS appeared first on ALS News Today.